Dr Reddys Labs gets one USFDA observation for Hyderabad facility Ruchika Sharma6 May 2023 12:30 PM ISTHyderabad: Pharma major, Dr Reddy's Labs, has recently announced that the United States Food & Drug Administration (USFDA) has issued a Form 483...
Dr Reddy's Labs unveils Treprostinil Injection in US Ruchika Sharma22 April 2023 12:30 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. has announced the launch of Treprostinil Injection in the U.S. market, a therapeutic equivalent generic ...
Dr Reddy's Labs names Sonu Sood as brand ambassador for Rebalanz Vitors Ruchika Sharma19 April 2023 3:45 PM ISTRebalanz Vitors is available at chemist stores in Andhra Pradesh, Telangana, Karnataka and Orissa and on Big Basket.
Dr Reddys Labs concludes acquisition of Mayne Pharma's US generic prescription product portfolio Ruchika Sharma8 April 2023 1:00 PM ISTHyderabad: Pharma major, Dr Reddys Labs, has recently announced that the company has completed the acquisition of Mayne Pharma's U.S. generic...
Eris Lifesciences acquires 9 Dermatology brands from Dr Reddy's Labs for Rs 275 crore Ruchika Sharma17 March 2023 11:38 AM ISTThe brands are largely in cosmetology segments like anti-acne, moisturisers, cleansers, anti-ageing, hair health, melasma etc.
Dr Reddy's Labs recalls 4320 bottles of Tacrolimus Capsules in US over packaging error Ruchika Sharma9 March 2023 12:15 PM ISTDr Reddy's initiated the Class II nationwide recall on February 8 this year.
Dr Reddys Labs net profit up 77 percent at Rs 1247 crore in Q3 Ruchika Sharma28 Jan 2023 11:00 AM ISTHyderabad: Dr Reddy's Laboratories has reported a 77 percent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended...
Dr Reddy's labs completes clinical studies of Rituximab biosimilar for filing in US, Europe Ruchika Sharma20 Jan 2023 3:30 PM ISTWith the successful completion of these clinical studies, Dr. Reddy’s is now preparing to file Biologics License Application (BLA) / Marketing...
Dr Reddy's Labs acquires trademark rights of breast cancer drug from Pfizer Ruchika Sharma16 Jan 2023 11:00 AM ISTThe in-house product will be retailed in the Indian market at a reduction of 85% from the current MRP to increase affordability and access to...
Dr Reddy's Labs, Theranica collaborate for commercialisation of wearable migraine treatment Nerivio in India Ruchika Sharma12 Jan 2023 12:36 PM ISTNerivio is the FDA-cleared, prescribed, digitally connected, drug-free wearable device for the acute treatment of episodic and chronic migraine in...
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Tocilizumab biosimilar met primary, secondary endpoints in Phase 1 study: Dr Reddy's Labs Ruchika Sharma19 Dec 2022 5:14 PM ISTThe company is initiating a global Phase 3 study with the aim of comparing the efficacy, safety, tolerability and immunogenicity of DRL_TC with the...
